Search research articles
Contact Us
Filters
Showing results (1-10 of 334) with videos related to
Page
of 34
Sort By:
Circulation
|
April 14, 2020
Willingness to Pay for High-Cost Medications
Mark A Hlatky
Journal of the American College of Cardiology
|
February 21, 2004
Comorbidity and outcome in patients with coronary artery disease
Mark A Hlatky
American Heart Journal
|
June 25, 2004
Coronary revascularization and quality of life
Mark A Hlatky
Circulation. Cardiovascular Quality and Outcomes
|
March 13, 2014
To test or not to test, that is the question
Mark A Hlatky
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing
|
December 19, 2012
Volume, outcome, and policy
Mark A Hlatky
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 28, 2016
Considering Cost-Effectiveness in Cardiology Clinical Guidelines: Progress and Prospects
Mark A Hlatky
JAMA Cardiology
|
March 30, 2017
Are Novel Anticoagulants Worth Their Cost?
Mark A Hlatky
Circulation
|
February 23, 2013
Effectiveness is the key to cost-effectiveness
Mark A Hlatky
Epidemiologic Reviews
|
July 18, 2002
Economic endpoints in clinical trials
Mark A Hlatky
The New England Journal of Medicine
|
November 11, 2008
Expanding the orbit of primary prevention--moving beyond JUPITER
Mark A Hlatky
Page
of 34
Search research articles
Search
Showing results (1-10 of 334) with videos related to
Sort By:
Page
of 34
Circulation
|
April 14, 2020
Willingness to Pay for High-Cost Medications
Mark A Hlatky
Journal of the American College of Cardiology
|
February 21, 2004
Comorbidity and outcome in patients with coronary artery disease
Mark A Hlatky
American Heart Journal
|
June 25, 2004
Coronary revascularization and quality of life
Mark A Hlatky
Circulation. Cardiovascular Quality and Outcomes
|
March 13, 2014
To test or not to test, that is the question
Mark A Hlatky
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing
|
December 19, 2012
Volume, outcome, and policy
Mark A Hlatky
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 28, 2016
Considering Cost-Effectiveness in Cardiology Clinical Guidelines: Progress and Prospects
Mark A Hlatky
JAMA Cardiology
|
March 30, 2017
Are Novel Anticoagulants Worth Their Cost?
Mark A Hlatky
Circulation
|
February 23, 2013
Effectiveness is the key to cost-effectiveness
Mark A Hlatky
Epidemiologic Reviews
|
July 18, 2002
Economic endpoints in clinical trials
Mark A Hlatky
The New England Journal of Medicine
|
November 11, 2008
Expanding the orbit of primary prevention--moving beyond JUPITER
Mark A Hlatky
Page
of 34